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lncRNAs are acquiring increasing relevance as regulators in a wide spectrum of biological processes. The extreme heterogeneity in
the mechanisms of action of these molecules, however, makes them very diﬃcult to study, especially regarding their molecular
function. A novel lncRNA has been recently identiﬁed as the most enriched transcript in mouse developing thyroid. Due to its
genomic localization antisense to the protein-encoding Klhl14 gene, we named it Klhl14-AS. In this paper, we highlight that
mouse Klhl14-AS produces at least ﬁve splicing variants, some of which have not been previously described. Klhl14-AS is
expressed with a peculiar pattern, characterized by diverse relative abundance of its isoforms in diﬀerent mouse tissues. We
examine the whole expression level of Klhl14-AS in a panel of adult mouse tissues, showing that it is expressed in the thyroid,
lung, kidney, testis, ovary, brain, and spleen, although at diﬀerent levels. In situ hybridization analysis reveals that, in the context
of each organ, Klhl14-AS shows a cell type-speciﬁc expression. Interestingly, databases report a similar expression proﬁle for
human Klhl14-AS. Our observations suggest that this lncRNA could play cell type-speciﬁc roles in several organs and pave the
way for functional characterization of this gene in appropriate biological contexts.
1. Introduction
In the last few years, genome comparison across diﬀerent
species highlighted that, on the evolutionary scale, organis-
mal complexity is directly correlated with the extent of the
nonprotein coding (herein referred as noncoding) fraction
of the total genome [1, 2]. Moreover, the discovery that
the vast majority of the genome is transcribed revealed
that the noncoding portion of eukaryote transcriptomes
largely exceeds the protein-coding one, both in abundance
and in complexity [3, 4]. These observations, together with
accumulating evidences of a plethora of RNA-mediated
gene regulatory networks, strongly suggested, hence, that
noncoding RNAs are key players in the establishment of
biological complexity [2, 5].
Noncoding RNAs are mainly classiﬁed according to their
length into small and long noncoding RNAs (lncRNAs).
LncRNAs are RNA molecules longer than 200 nucleotides
and without any evident or conserved open reading frame.
They are often 5′ capped, polyadenylated, and spliced and
have been described to be expressed at levels lower than
protein-coding genes but in a more tissue- and cell-speciﬁc
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manner [6–10]. Many of these transcripts have been reported
to have potential functional orthologs in diﬀerent species,
despite the low sequence conservation [8, 11–13]. Although
only few lncRNAs have been functionally characterized
[14, 15], the number of lncRNAs identiﬁed in diﬀerent cell
types and correlating with diﬀerent biological processes has
been rising [1, 16, 17]. Such increase strongly suggests that
they have multiple considerable functions, mainly mediated
by their ability to associate with diﬀerent classes of biomole-
cules. Indeed, long noncoding RNAs can be able to bind to
other nucleic acids (either DNA or RNA) by base pairing to
complementary sequences and/or to bind to proteins by fold-
ing in secondary structures [1, 18–20]. Nevertheless, the
intrinsic pleiotropic mechanism of action of these molecules
represents the major challenge in the study of the functional
role of each individual lncRNA.
Recently a poorly characterized gene, reported as long
noncoding RNA, emerged as the most enriched in E10.5
mouse thyroid bud transcriptome, compared to that of the
whole embryo [21]. To the best of our knowledge, only few
data exist in the literature about this gene, which are essen-
tially based on genome-wide expression proﬁling of lncRNAs
in mouse [9]. We ﬁrstly named it Thybe1 (thyroid bud
enriched 1); however, the analysis of its genomic localization
revealed that it is in antisense and partially overlapping with
the protein-encoding gene Klhl14 in a head to head arrange-
ment; thus, a more standard name for this gene could be
Klhl14-AS. In this paper, we analyze the Thybe1/Klhl14-AS
expression pattern in adultmouse tissues, both by quantitative
real-time reverse-transcriptase- (qRT-) PCR and by in situ
hybridization (ISH). We also identify previously unknown
splicing isoforms of this gene in mouse and explore available
data on human Klhl14-AS expression, thus providing an
important contribution to the characterization of this
novel lncRNA.
2. Results and Discussion
2.1. Genomic Organization and Identiﬁcation of Alternative
Transcripts of Mouse Klhl14-AS Gene. To shed light on the
Klhl14-AS expression proﬁle, we looked at diﬀerent data-
bases such as NCBI [22], UCSC [23], and Ensembl [24] to
obtain information about gene structure and expression. In
mouse genome, the gene is named 4930426D05Rik and
mapped to chromosome 18qA2, as reported in Ensembl. In
human genome, its ortholog is named AC012123.1 and
mapped to chromosome 18q12.1. The comparison of the
genomic context of mouse and human locus reveals that
the regions are clearly syntenic and show high grade of con-
servation of blocks of sequences. In both genomes, Klhl14-
AS partially overlaps with the protein-coding gene Klhl14
in a head-to-head antisense arrangement (Figure 1(a)).
Mouse Klhl14-AS produces several diﬀerent transcripts
(Figure 1(b)) diﬀering between databases both in number
and in structure (see Supplementary Figure S1 available online
at https://doi.org/10.1155/2017/9769171), while in human, it
is reported to produce a single isoform (Figure 1(c)). We thus
referred to Ensembl for further analyses, because it reports
the higher number of alternative transcripts for mouse. In
Figure 1(b), it is shown that mouse Klhl14-AS produces four
transcripts named 4930426D05Rik 002, 003, 004, and 005.
These transcripts diﬀer for the transcription start site and/
or the exons, mainly at the 5′moiety, while three out of four
show a similar 3′ end, with only Rik04 showing a longer 3′
exon. All the isoforms, however, share three regions indi-
cated in Figure 1(b) by blue, orange, and green rectangles.
As Klhl14-AS was identiﬁed in the developing thyroid
[21], we decided to investigate which of the reported tran-
scripts was expressed in the adult mouse gland. We thus
designed appropriate primer sets and ampliﬁed total mouse
thyroid cDNA. Surprisingly, only one out of the used oligo
sets, including the most internal ones, gave rise to amplicons
(see Figure S2 and Table S1). This prompted us to experi-
mentally map 5′and 3′ends of thyroid isoforms by perform-
ing RACE experiments. To this aim, we started from the 5′
end of the common region in the blue box and the 3′ end of
the common region in the green box (Figure 1(b)), by identi-
fying a 5′ terminus and a polyadenylated 3′ end (data not
shown). Moreover, we considered also a more upstream
CAGE site reported in Encode, in a region shared by most
5′ exons of the Rik002 and Rik005 isoforms. Two diﬀerent
primer sets were thus designed, starting from the just
described putative ends. The oligo starting from the 5′RACE
sequence was used in set 1, whereas the oligo starting from
the most upstream sequence reported in databases was used
in set 2 (Figure S3). For each oligo set, the reverse primer
was speciﬁcally designed to optimize the ampliﬁcation condi-
tions, although reverse primers are largely overlapping and
both mapped very closely to the 3′ end identiﬁed by RACE.
RT-PCR performed with oligo set 1 produced two products,
named A and B, while that performed with oligo set 2 pro-
duced three fragments, named C, D, and E (Figure 2, see
the thyroid lane). The sequences of the isoforms ampliﬁed
were mapped to the mouse genome (mm10) using BLAT
(see Materials and Methods), revealing that only the two of
them, A and D, correspond to the previously characterized
splicing variants, Rik004 and Rik005, respectively. Impor-
tantly, we identiﬁed three novel isoforms, B, C, and E,
which have not been previously annotated (Figure 1(b)). It
is worth noting that we found a region that is ampliﬁed only
using oligo set 1 (Figure 1(b), pink rectangle). The retention
of this region only in transcripts A and B suggests that at
least two diﬀerent TSSs could exist for this gene. The ﬁnd-
ing that Klhl14-AS is transcribed in several diﬀerent iso-
forms in the same organ suggests that they could play
diﬀerent roles through the binding of diﬀerent interactors.
Moreover, the presence of more than one TSS suggests that
Klhl14-AS transcription could be diﬀerentially regulated in
diﬀerent conditions.
2.2. Expression Proﬁle of Klhl14-AS in Adult Mouse Tissues.
We asked if Klhl14-AS was expressed in other organs. To
answer this question, we performed the above described
ampliﬁcations in diverse adult mouse tissues. Such analysis
indicated that Klhl14-AS transcripts are diﬀerentially
expressed in diﬀerent tissues and that the two used oligo sets
amplify the same molecular species in all tested tissues
(Figure 2). Indeed, isoforms A and B are expressed in the
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Figure 1: Genomic context of the Klhl14 S/AS pair in mouse and human. In (a), two genomic segments from mouse and human containing
the Klhl14 S/AS pair and ﬂanking genes are displayed. The regions are clearly syntenic, and the presence of an antisense noncoding gene (red
circle) is conserved in both species. Pink boxes indicate conserved blocks, and green lines represent their correspondences. In (b) and (c), the
slices are zoomed in to show the entire AS genes and the Klhl14 gene portion in overlap for the mouse (b) and human (c) genome,
respectively. The constrained elements displayed as grey boxes represent regions of sequence conservation in mammals according to
Ensembl. In (b), the regions shared by all the transcripts are indicated by the blue, orange, and green boxes. Fragment A to fragment E
represent the isoforms identiﬁed in this study with the new ones indicated by the red arrows. The region in the pink rectangle is ampliﬁed
exclusively with one set of oligos.
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Figure 2: Klhl14-AS isoform expression in adult mouse tissues. Klhl14-AS transcripts were ampliﬁed by RT-PCR on total RNA from adult
mouse organs. Three diﬀerent PCR reactions were performed on the same template cDNA. Upper image: A and B isoforms were ampliﬁed by
using the oligo set 1; middle image: C, D, and E were obtained by using oligo set 2; lower image: Abelson (Abl) ampliﬁcation was performed as
the control (for details see Materials and Methods). Data are representative of three independent experiments.
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thyroid, kidney, testis, ovary, brain, and spleen, although at
diﬀerent extents. A is mostly represented in the testis and
ovary, being also strongly expressed in the thyroid and kid-
ney. B is relatively more abundant in the brain than in other
organs. The transcript C is mostly expressed in the thyroid
and kidney. D is weakly expressed in the thyroid and kidney,
while it is highly expressed only in the brain. E is mostly
represented in the thyroid, testis, ovary, and brain. It is
worth noting that all the identiﬁed transcripts are expressed
in the thyroid gland, whereas none of the transcripts ampli-
ﬁed by oligo set 2 are expressed in the spleen. Lastly, the
liver and heart are negative for Klhl14-AS expression, while
the lung shows a weak signal only with oligo set 1. Such data
reveal a tissue-speciﬁc pattern of Klhl14-AS alternative tran-
script expression.
To overcome the complexity of the alternatively spliced
isoform expression, we analyzed Klhl14-AS expression by
using a primer set amplifying a region that is common
between all known isoforms (overlapping the common splice
junction between the regions included in the orange and
green rectangles in Figure 1). Whole Klhl14-AS expression
among adult tissues was evaluated through qRT-PCR, show-
ing that it is expressed in several organs at diﬀerent extents.
This quantitative analysis conﬁrms that the lncRNA is not
expressed in the liver and heart; weakly expressed in the
brain, lung, ovary, and testis; and more strongly expressed
in the kidney, spleen, and thyroid gland (Figure 3). However,
qRT-PCR, such as the standard PCR previously performed,
measures the RNA in the whole organ, thus missing the pos-
sible diﬀerences between diﬀerent cells types in the same
organ. This technical limit could lead to underestimating
Klhl14-AS presence in speciﬁc cell types. To deal with this
problem, we performed ISH analysis by using a Klhl14-AS-
speciﬁc probe that allowed to clearly deﬁne the lncRNA dis-
tribution in speciﬁc cellular types. A sense probe was used as
a control (Figure S4). ISH performed on adult mouse organs,
while conﬁrming qRT-PCR results, revealed that Klhl14-AS
is expressed in a cell type-restricted manner in the context
of each organ. As expected, Klhl14-AS staining is absent in
the liver and heart (Figure 4(a)). Unexpectedly, Klhl14-AS
staining is absent also in the lungs (Figure 4(a)), where the
qRT-PCR showed a detectable although weak positivity
(Figure 3). One possible explanation is that ISH has a lower
detection capability than qRT-PCR; thus, a weak level of
expression could be undetectable by ISH. Conversely, all
other organs positive for Klhl14-AS expression by qRT-
PCR show a clear signal by ISH, with diﬀerences in the dis-
tribution between speciﬁc cell types (Figure 4(b)). In the
thyroid, the lncRNA is highly expressed in follicular cells,
representing the epithelial component of thyroid follicles.
In the kidney, Klhl14-AS is mainly expressed in the renal
corpuscles of the cortex (see 200x magniﬁcation). In the
spleen, it is expressed in the rounded areas of white pulp
consisting of lymphoid cells, while it is not detected in the
red pulp (see 25x magniﬁcation). In the testis, the lncRNA
is expressed in the seminiferous tubules, while resulting neg-
ative in the Leydig cells of the intertubular connective tissue
(see 200x magniﬁcation). In the ovary, Klhl14-AS is
expressed in the follicles, showing a strong signal in granu-
losa cells of the preovulatory follicles, while it was negative
in the oocyte and theca cells (see 200x magniﬁcation).
Figure 4(c) shows the ISH of the brain, where Klhl14-AS
expression is strongly detected in the hippocampus and
the in cortex (see 200x magniﬁcation).
We also did a survey of existing data about the human
Klhl14-AS ortholog expression pattern. Gtex annotations in
the UCSC database, obtained by RNA sequencing, report
that the lncRNA is strongly expressed in the thyroid but
weakly expressed in the spleen, testis, kidney cortex, and
fallopian tube (Supplementary Figure S5) (http://bit.ly/
klhl14-as). The expression pattern of human Klhl14-AS
overlaps in part to that shown here in mouse, at least for
the organs with the highest expression levels. The diﬀerences
observed for some organs (i.e. brain, ovary) could be due
either to the diﬀerent experimental approaches or to real
diﬀerences between the two species.
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Figure 3: Klhl14-AS expression in adult mouse organs. Quantitative real-time RT-PCR was performed by amplifying a region shared by
Klhl14-AS isoforms on total RNA from adult mouse organs. The data are reported as normalized by Abelson expression. Three replicates
for each experimental point were performed. Error bars represent standard deviation of normalized ct values. Data are representative of
three independent experiments.
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Figure 4: Cell type-speciﬁc expression of Klhl14-AS in adult mouse organs. In situ hybridization was performed on paraﬃn-embedded
sections with a probe recognizing all Klhl14-AS isoforms (for details, see Materials and Methods). (a) The lung, liver, and heart are
negative for Klhl14-AS staining. 25x magniﬁcations are shown. (b) The thyroid, kidney, spleen, testis, and ovary are positive for Klhl14-AS
staining. For each organ, three diﬀerent magniﬁcations are shown: 25x, 200x, and 400x. 200x magniﬁcations correspond to the areas
boxed in 25x pictures, while 400x magniﬁcations correspond to areas boxed in 200x pictures. RC: renal corpuscle; RP: red pulp; WP: white
pulp; L: Leydig cells; ST: seminiferous tubule; OC: oocyte; G: granulosa cells; T: thecal cells. All the images are reduced by 70% compared
to the original ones. Data are representative of three independent experiments.
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The conservation of Klhl14-AS sequence and genomic
organization, together with a partially overlapping expres-
sion pattern, is suggestive of an important biological role of
Klhl14-AS.
3. Conclusion
Identifying the biological role and the mechanism of action
of long noncoding RNAs is among the most challenging
issues in functional genetics studies, where the setting of
appropriate experimental models is a critical issue, given
their tissue speciﬁcity. Klhl14-AS was the ﬁrst lncRNA iden-
tiﬁed in the thyroid gland, and here, we demonstrate that it is
also expressed in very diﬀerent tissues such as those of the
kidney and brain. Moreover, we identify previously unchar-
acterized Klhl14-AS alternatively spliced transcripts and
describe the diﬀerential expression pattern in several organs,
suggesting that each isoform could play a speciﬁc role in a
given physiological context. Indeed, the functional speciﬁcity
of Klhl14-AS could arise by the combination of diﬀerent var-
iants with cell type-speciﬁc interactors that likely take place
in diﬀerent tissues. Taken together, our data represent the
starting point for the characterization of this lncRNA, which
is likely to be involved in relevant biological phenomena and
possibly in diﬀerent diseases.
4. Materials and Methods
4.1. Animal Experiments. All animal experiments were per-
formed in accordance with the Italian and European guide-
lines and were approved by the local Ethical Committee
and by the Italian Ministry of Health. Animals were main-
tained under speciﬁc pathogen-free conditions in the animal
house facility of the Dipartimento di Medicina Molecolare e
Biotecnologie Mediche. A total of eight wild-type C57BL/6
mice of both sexes were used for both molecular and histo-
logical analyses.
4.2. Transcript Mapping. 5′and 3′ends were investigated with
the use of 3′ RACE System (Invitrogen 18373-027) and 5′
RACE System (Invitrogen 18374-041) according to the man-
ufacturer’s speciﬁcations.
cDNA from adult mouse tissues were ampliﬁed with the
Pwo SuperYield DNA Polymerase (Roche 04 340 850 001)
using oligos representing the ends obtained through RACE
experiments and the 5′ oligo designed on the second
upstream CAGE site reported in UCSC—Klhl14-AS CAGE
II: CGCGTACTGCATGCGGGTCTCA, Klhl14-AS 5′RACE:
GAGAGAGGAACAACAATCAAGGC, Klhl14-AS 3′RACE:
GGGGATTAGAGTTTATTTTTGTCATCTC, and Klhl14-
AS 3′RACE inner: ATTCATCCAGATCACAGCTAAG.
The sequences from the identiﬁed isoforms in FASTA for-
mat were mapped to the mouse genome (mm10) using BLAT
(https://genome.ucsc.edu/cgi-bin/hgBlat), and the results
were exported in PSL format. The results in PSL format were
uploaded as a custom track in the UCSC browser and
converted into GTF using the UCSC table browser. The
genome browser images were generated using the Ensembl
genome browser (v88) for human (GRCh38.p10) and mouse
(GRCm38.p5) where a custom track was created and
uploaded to visualize the PCR fragment mappings in GTF
format on the mouse genome. The genome browser screen-
shots were exported in PDF format, and processing of the vec-
tor graphics was done in Inkscape (v0.48.4).
4.3. Quantitative Real-Time PCR. Total RNA was isolated
from mouse organs as previously described [25] using TRI-
zol® Reagent (Invitrogen 15596026) according to the manu-
facturer’s speciﬁcations. Each sample corresponds to a single
organ except the thyroid. Due to the small size of mouse thy-
roid, two glands were pooled for total RNA extraction. Total
cDNA was generated with the SuperScript® III First-Strand
Synthesis System for RT-PCR (Invitrogen 18080051), accord-
ing to the manufacturer’s speciﬁcations. Real-time PCR on
total cDNA was performed with iTaq™ Universal SyBR®
Green Supermix (Bio-Rad 172-5124) using gene-speciﬁc
oligos—Klhl14-AS F: GGCTCCTCTCCACTCACTTTC,
Klhl14-AS R: TCAGCTCAGCAGCGAAGTC, Abelson F:
TCGGACGTGTGGGCATT, and Abelson R: CGCATGA
GCTCGTAGACCTTC.
4.4. In Situ Hybridization. Organs were ﬁxed in 4% PFA
(overnight, 4°C), washed in saline solution, dehydrated in
solutions at increasing ethanol concentration from 70% to
100% (overnight, 4°C), and paraﬃn-embedded at 60°C after
xylene soaking. The period of each step is determined
according to the size of the processed sample.
Paraﬃn-embedded samples were sliced in 7 μm sections
and analyzed. To perform the in situ hybridization, the sec-
tions were deparaﬃnized in xylene and rehydrated with
EtOH 100% to EtOH 50%. After rehydration, the hybridiza-
tion was performed as described in Fagman et al. [21], using a
speciﬁc probe for Klhl14-AS ampliﬁed with Pwo SuperYield
DNA Polymerase from adult mouse thyroid cDNA using
the following oligos—Klhl14-AS sp6: GGCTGAACAGGA
AGGGACCCT and Klhl14-AS T7: CAGATCACAGCTAA
GAAAAAAGC.
PCR product was puriﬁed using the USB® PrepEase®
Gel Extraction Kit (Aﬀymetrix 78756). Digoxigenin-
labelled riboprobes (sense and antisense) were obtained
using the DIG-labeling RNA kit (Roche Diagnostics Basel,
Switzerland) following the manufacturer’s instructions. No
signal was detected with the sense riboprobes (not shown).
Images were obtained using an Axioskop microscope
equipped with an Axiocam 105 color digital camera (Zeiss,
Oberkochen, Germany). Images were processed using the
Axion Vision software.
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